drugset / Trial / NCT01995136

Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma

NCT01995136

Phase 4 Completed 32 enrolled Alcon Research
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate IOP reduction efficacy of travoprost 0.004% ophthalmic solution (TRAVATAN Z®) in subjects with normal tension glaucoma.

Timeline

Start
2013-09
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Travoprost Other / unclassified 0.004 % Other